These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 2560598
1. Acetylator phenotype and short-course chemotherapy for tuberculosis in Papua New Guinea. Currie B, Krause V, Mondia P, Hudson B. P N G Med J; 1989 Dec; 32(4):259-62. PubMed ID: 2560598 [Abstract] [Full Text] [Related]
2. Exacerbation of isoniazid induced peripheral neuropathy by pyridoxine. Nisar M, Watkin SW, Bucknall RC, Agnew RA. Thorax; 1990 May; 45(5):419-20. PubMed ID: 2166360 [Abstract] [Full Text] [Related]
3. Relationship between N-acetylator phenotype and susceptibility toward hydrazine-induced lethal central nervous system toxicity in the rabbit. Hein DW, Weber WW. J Pharmacol Exp Ther; 1984 Mar; 228(3):588-92. PubMed ID: 6707910 [Abstract] [Full Text] [Related]
4. Pyridoxine supplementation during isoniazid therapy. Snider DE. Tubercle; 1980 Dec; 61(4):191-6. PubMed ID: 6269259 [Abstract] [Full Text] [Related]
5. Peripheral neuropathy secondary to isoniazid-induced pyridoxine deficiency. Aita JF, Calame TR. Md State Med J; 1972 Oct; 21(10):68-70. PubMed ID: 4353461 [No Abstract] [Full Text] [Related]
6. Acetylator phenotypes in Papua New Guinea. Penketh RJ, Gibney SF, Nurse GT, Hopkinson DA. J Med Genet; 1983 Feb; 20(1):37-40. PubMed ID: 6842533 [Abstract] [Full Text] [Related]
8. [Isoniazid induced neuropathy: consider prevention]. Steichen O, Martinez-Almoyna L, De Broucker T. Rev Mal Respir; 2006 Apr; 23(2 Pt 1):157-60. PubMed ID: 16788441 [Abstract] [Full Text] [Related]
9. [Axonal neuropathy and salazosulfapyridine: slow-acetylator phenotype]. Blin O, Sangla I, Jouglard J, Cottin C, Pellissier JF, Serratrice G. Rev Neurol (Paris); 1992 Apr; 148(2):154-6. PubMed ID: 1351312 [Abstract] [Full Text] [Related]
10. An assessment of acetylator polymorphism and its relevance in Papua New Guinea. Hombhanje F. P N G Med J; 1990 Jun; 33(2):107-10. PubMed ID: 2238823 [Abstract] [Full Text] [Related]
11. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis. Singh SP, Pande JN, Khilnani GC, Kailash S. Indian J Chest Dis Allied Sci; 1996 Jun; 38(1):5-11. PubMed ID: 16892742 [Abstract] [Full Text] [Related]
12. [Acetylation phenotype of isoniazid in Morocco. Preliminary study of 100 cases]. Bouayad Z, Chevalier B, Maurin R, Bartal M. Rev Fr Mal Respir; 1982 Jun; 10(6):401-7. PubMed ID: 7163595 [Abstract] [Full Text] [Related]
13. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid. Ylitalo P, Auterinen L, Marttinen A, Koivula T. Int J Clin Pharmacol Res; 1984 Jun; 4(2):141-4. PubMed ID: 6469440 [Abstract] [Full Text] [Related]
14. Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis. Ena J, Valls V. Clin Infect Dis; 2005 Mar 01; 40(5):670-6. PubMed ID: 15714411 [Abstract] [Full Text] [Related]
15. Acetylator status, drug metabolism and disease. Pande JN, Pande A, Singh SP. Natl Med J India; 2003 Mar 01; 16(1):24-6. PubMed ID: 12715953 [Abstract] [Full Text] [Related]
16. Isoniazid induced motor-dominant neuropathy. Arsalan R, Sabzwari S. J Pak Med Assoc; 2015 Oct 01; 65(10):1131-3. PubMed ID: 26440850 [Abstract] [Full Text] [Related]
17. Pyridoxine supplementation with isonex: is it necessary? Maheshwari RK, Gupta BD. Indian Pediatr; 1991 Sep 01; 28(9):1085-7; author reply 1087-8. PubMed ID: 1802853 [No Abstract] [Full Text] [Related]
18. [Adjusting or not adjusting isoniazid dosage?]. Parrot R, Boval C, Grosset J, Gaillard JP. Rev Fr Mal Respir; 1983 Sep 01; 11(5):705-12. PubMed ID: 6658156 [Abstract] [Full Text] [Related]
19. The management of asthma in children in Papua New Guinea. Vince JD. P N G Med J; 1996 Dec 01; 39(4):329-37. PubMed ID: 10214092 [Abstract] [Full Text] [Related]
20. The type of isoniazid acetylation in tuberculosis patients treated at National Tuberculosis and Lung Diseases Research Institute. Augustynowicz-Kopeć E, Zwolska Z. Acta Pol Pharm; 2002 Dec 01; 59(6):443-7. PubMed ID: 12669768 [Abstract] [Full Text] [Related] Page: [Next] [New Search]